GLORIA PHARMA: Net profit in the first half of 2025 increased by 7.56% year-on-year

GLORIA PHARMA announced that in the first half of 2025, the company achieved operating revenue of 1.1 billion yuan, a year-on-year decrease of 9.97%; the net profit attributable to shareholders of the listed company was 134 million yuan, a year-on-year increase of 7.56%; the basic earnings per share were 0.0613 yuan/share, a year-on-year increase of 10.25%